Samson Clinical Announces Last Patient Last Visit in Pivotal Phase III Study of Sublingual Minoxidil for Male Baldness
MELBOURNE, VICTORIA, AUSTRALIA, May 19, 2026 /EINPresswire.com/ -- Samson Clinical Operations Pty Ltd (Samson) announced completion of the Last Patient Last Visit in its pivotal Phase III clinical trial evaluating low dose sublingual minoxidil in …